Literature DB >> 6821192

Inhibition of trypsin and papain by sodium aurothiomalate mediated by exchange reactions.

M M Griffin, F S Steven.   

Abstract

Sodium aurothiomalate has been shown to participate in exchange reactions leading to the inhibition of trypsin; for this exchange to take place it was necessary to include in the test system a suitable thiol, such as N-acetyl-cysteine. Neither N-acetyl-cysteine nor aurothiomalate on their own had any inhibitory action on trypsin. The results indicate that aurothiomalate dissociates in the presence of a carrier to form thiosuccinate and gold. The gold is responsible for trypsin inhibition since independent experiments demonstrated that the total concentration of thiosuccinate was insufficient to cause the observed inhibition of trypsin. Bovine serum albumin was shown to act as a carrier in place of N-acetyl-cysteine. It is known that histidine in the active centre of trypsin binds heavy metal ions with consequent inhibition of the enzyme. In this study, imidazole was shown to act as a carrier for gold from aurothiomalate to trypsin resulting in inhibition. This inhibition by gold was reversed when higher concentrations of imidazole were added to the test system due to competition for the trypsin-bound gold by imidazole. Conversely, the thiol enzyme papain was re-activated in the presence of low concentrations of sodium aurothiomalate and inhibited by higher concentrations of this reagent in a biphasic manner. This observation will be discussed in relation to the dissociation of sodium aurothiomalate. These observations can also be explained in terms of exchange reactions involving thiols and free metal ions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6821192      PMCID: PMC2071598          DOI: 10.1111/j.1476-5381.1982.tb08791.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Gold compounds in rheumatoid arthritis: clinical-pharmacokinetic correlates.

Authors:  N L Gottlieb
Journal:  J Rheumatol Suppl       Date:  1979

2.  The hydrolysis of carbobenzoxy-L-tyrosine p-nitrophenyl ester by various enzymes.

Authors:  C J MARTIN; J GOLUBOW; A E AXELROD
Journal:  J Biol Chem       Date:  1959-07       Impact factor: 5.157

3.  Properties of dipeptidyl arylamidase I of the pituitary. Chloride and sulfhydryl activation of seryltyrosyl-beta-naphthylamide hydrolysis.

Authors:  J K McDonald; S Ellis; T J Reilly
Journal:  J Biol Chem       Date:  1966-04-10       Impact factor: 5.157

4.  Gold metabolism in patients with rheumatoid arthritis treated with gold compounds--reinvestigated.

Authors:  B R Mascarenhas; J L Granda; R H Freyberg
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

5.  Biphasic kinetics of metal ion reactivation of trypsin-thiol complexes.

Authors:  F S Steven; V Podrazký; A Al-Habib; M M Griffin
Journal:  Biochim Biophys Acta       Date:  1979-12-07

6.  A neutral protease in rheumatoid synovial fluid capable of attacking the telopeptide regions of polymeric collagen fibrils.

Authors:  F S Steven; A Torre-Blanco; J A Hunter
Journal:  Biochim Biophys Acta       Date:  1975-09-09

7.  Action of gold salts on the inflammatory response and inflammatory cell function.

Authors:  B Vernon-Roberts
Journal:  J Rheumatol Suppl       Date:  1979

8.  Evidence for the inhibition of trypsin by thiols. The mechanism of enzyme-inhibitor complex formation.

Authors:  F S Steven; V Podrazký
Journal:  Eur J Biochem       Date:  1978-02-01

9.  Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.

Authors:  E Jellum; E Munthe; G Guldal; J Aaseth
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

  9 in total
  3 in total

1.  Inhibition of lymphocyte activation by gold sodium thiomalate.

Authors:  S J Hopkins; M I Jayson; P Van der Zeil
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

2.  Gold-containing drugs and the control of proteolytic enzymes.

Authors:  D Rohozková; F S Steven
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

3.  Evidence for the carriage of silver by sulphadimidine: inhibition of proteolytic enzymes.

Authors:  P M Ballinger; M M Griffin; S Itzhaki; F S Stevens
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.